ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.
about
ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.
@en
ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.
@nl
type
label
ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.
@en
ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.
@nl
prefLabel
ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.
@en
ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.
@nl
P2093
P2860
P1476
ER-α36 mediates cisplatin resi ...... R/HER-2/ERK signaling pathway.
@en
P2093
Linlin Zhu
Xiangwei Wang
Xiaomei Jiang
Yuanyin Zhao
P2860
P2888
P356
10.1186/S13046-018-0798-Z
P577
2018-06-25T00:00:00Z
P6179
1105096559